Delivering future health solutions.
Health & Life Sciences
Major European Biomanufacturing cluster
Highest number of specialist hospitals outside of London
Home to the world renowned Liverpool School of Tropical Medicine
The highest concentration of Category Level 3 laboratories in the UK
There is no better validation of Liverpool City Region’s medical credentials than the global players that choose to locate and reinvest here. From stem cell and gene therapy treatments and nutraceuticals research and development, to large scale manufacturing and the production of pharmaceuticals, vaccines and biologics.
Liverpool City region is home to companies delivering world-class solutions in life sciences from research and trials to medical manufacturing, including AstraZeneca; Allergan; Baxter Healthcare, Bristol Myers Squibb; Lilly; Nestlé Health Science; Seqirus and Unilever. Significant new investments in modern production facilities at these companies have created a vibrant, efficient and cost-competitive environment to produce new drugs and vaccines.
The emergence of sensor technologies, big data and robotics is changing the possibilities and processes in the life sciences sector. Liverpool City Region is leading the way with its LCR 4.0 programme, creating a new infrastructure that connects physical and digital assets to make the industrial internet a reality. The Hartree Centre at Sci-Tech Daresbury is shaping the future of digital UK pharmaceutical design, development and manufacturing through big data analytics expertise.
Get in touch
- +44(0)151 237 3918
Latest Health & Life Sciences news
BioGrad Limited reports record turnover
One of the UK’s largest national education providers and Covid-19 testing firms, BioGrad Limited, has reported huge growth and profitability for the fiscal year ending September 2021.
Public Consultation event to be held for HEMISPHERE
Sciontec will reveal their plans for the next Paddington Village development, at a community drop-in session next week.
iiCON SUPPORTS 11 NEW PRODUCTS TO MARKET IN FIRST 18 MONTHS
iiCON: Infection Innovation Consortium has supported 11 new products to market since launching in September 2020, with a further 16 in the development pipeline.
Liverpool scientists develop synthetic antibiotics that could save millions of lives
University of Liverpool scientists have taken a significant step towards unlocking the medical potential of a new class of potent antibiotic capable of killing ‘superbugs’ including MRSA without detectable resistance.
Sci-Tech Daresbury’s global standing cemented as international innovators sign up to Violet
Two leading international firms have become the first companies to take residence within Sci-Tech Daresbury’s Violet development, representing a significant coup for the Liverpool City Region campus.
Liverpool City Region’s NeedleSmart to save NHS almost £250 million a year
A Liverpool city region healthcare tech firm could save the NHS up to £247m a year through prevention of needlestick injuries and cutting down single-use plastic.
CPI EXPANDS INTO LIVERPOOL SCIENCE PARK
CPI’s new presence in Liverpool will help drive innovation and economic growth in the region.